Literature DB >> 17599048

A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome.

M Sanchez-Cespedes1.   

Abstract

Germline LKB1 mutations are responsible for Peutz-Jeghers syndrome (PJS). Tumors at several locations frequently arise in these patients, confirming that LKB1 is linked to cancer predisposition and is therefore a bona fide tumor-suppressor gene. In humans, the LKB1 gene is located in the short arm of chromosome 19, which is frequently deleted in many tumors of sporadic origin. However, LKB1 alterations in tumors other than those of PJS are rarely reported. Notably, this is not the case for non-small-cell lung cancer, where nearly half of the tumors harbor somatic and homozygous inactivating mutations in LKB1. The present review considers the frequency and pattern of LKB1 gene mutations in sporadic cancers of various origins, and the role of the encoded protein in cancer development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599048     DOI: 10.1038/sj.onc.1210594

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  111 in total

Review 1.  Epithelial cell polarity, stem cells and cancer.

Authors:  Fernando Martin-Belmonte; Mirna Perez-Moreno
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

2.  Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma.

Authors:  Yevgeniya A Byekova; Jennifer L Herrmann; Jianmin Xu; Craig A Elmets; Mohammad Athar
Journal:  Arch Biochem Biophys       Date:  2011-01-25       Impact factor: 4.013

Review 3.  The role of LKB1 in lung cancer.

Authors:  Montse Sanchez-Cespedes
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

Review 5.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

6.  Frameshift Mutations of CAB39L, an Activator of LKB1 Tumor Suppressor, in Gastric and Colorectal Cancers.

Authors:  Mi Ryoung Choi; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2015-08-26       Impact factor: 3.201

7.  Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.

Authors:  Szu-Wei Lee; Chien-Feng Li; Guoxiang Jin; Zhen Cai; Fei Han; Chia-Hsin Chan; Wei-Lei Yang; Bin-Kui Li; Abdol Hossein Rezaeian; Hong-Yu Li; Hsuan-Ying Huang; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

Review 8.  PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.

Authors:  Vera P Krymskaya; Elena A Goncharova
Journal:  Cell Cycle       Date:  2009-02-06       Impact factor: 4.534

9.  Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells.

Authors:  Imoh S Okon; Kathleen A Coughlan; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

10.  Two novel STK11 missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome.

Authors:  Ran Li; Zhiqing Wang; Shu Liu; Baoping Wu; Di Zeng; Yali Zhang; Lanbo Gong; Feihong Deng; Haoxuan Zheng; Yadong Wang; Chudi Chen; Junsheng Chen; Bo Jiang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.